obesity drug news today october 21 2025 glp-1 weight loss drugs, such as Ozempic, have helped numerous people drop pounds, but according to a new study, these drugs aren't only good for weight loss. The study found that heart Outlook for obesity in 2025:

The optimal approach for many patients involves combining strategies

In January of 2024 we put in the requirement that you have type 2 diabetes for certain GLP-1s, and then we put in a BMI of 35 or higher for the weight loss GLP-1s

Fourth, small-molecule oral drugs may offer manufacturing and scalability advantages versus peptide-based injectables

Healthcare professionals are increasingly choosing treatment options that avoid the common challenges associated with insulin, including hypoglycemia, weight gain, and complicated dose adjustments

DrugBank 6.0: The DrugBank Knowledgebase for 2024

But it still occurs to some degree